Q9BX66 (SRBS1_HUMAN) Homo sapiens (Human)
Sorbin and SH3 domain-containing protein 1 UniProtKBInterProSTRINGInteractive Modelling
1292 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6; Isoform 7; Isoform 8; Isoform 9; Isoform 10; Isoform 11; Isoform 12)
It is possible new templates exist for this target since these models were created.
Available Structures
11 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| The second SH3 domain from CAP/Ponsin in complex with proline rich peptide from Vinculin |
Heteromer P18206; | |||||
| Assess | ||||||
| The first SH3 domain from CAP/Ponsin in complex with proline rich peptide from Vinculin |
Heteromer P18206; | |||||
| Assess | ||||||
| The second SH3 domain from Ponsin in complex with the paxillin proline rich region |
Heteromer P49023; | |||||
| Assess | ||||||
| solution structure of tandem SH3 domain of Sorbin and SH3 domain-containing protein 1 | monomer | |||||
| Assess | ||||||
| The third SH3 domain of R85FL | monomer | |||||
| Assess | ||||||
| The third SH3 domain of R85FL with ataxin-7 PRR | monomer | |||||
| Assess | ||||||
| The second SH3 domain from ponsin | monomer | 1×NA; 1×CL; 2×SCN; | ||||
| Assess | ||||||
| Crystal structure of the second SH3 domain from ponsin | monomer | 2×FMT; | ||||
| Assess | ||||||
| Extending powder diffraction to proteins: structure solution of the second SH3 domain from ponsin | monomer | |||||
| Assess | ||||||
| Solution structure of the SH3 domain of Sorbin and SH3 domain-containing protein 1 | monomer | |||||
| Assess | ||||||
| Solution structure of the first SH3 domain of human sorbin and Sh3 domain-containing protein 1 | monomer | |||||
| Assess | ||||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2lj1.1.A | monomer | 0.62 | 100.00 | |||
| Assess | ||||||
| 1gri.1.B | monomer | 0.59 | 33.85 | |||
| Assess | ||||||
| 2mox.1.A | monomer | 0.59 | 100.00 | |||
| Assess | ||||||